CorMedix Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +52.0% | +2.9% | +206.1% | -55.1% | +103.5% | – | |
| – | +4.9% | +16.9% | +252.2% | +0.7% | +72.7% | +21.2% | +0.5% | +2,227.1% | +175.3% | +1.1% | -200.0% | – | |
| – | +21.4% | +100.8% | -48.3% | -2.9% | -2.7% | +193.2% | -23.5% | +51.8% | -11.7% | +27.7% | -200.0% | – | |
| – | – | -295.3% | – | – | – | – | – | -451.9% | – | -207.3% | – | – | |
| – | +2,788.5% | -79.3% | -43.3% | -71.9% | +1.1% | +1.3% | +141.2% | +1,996.7% | +240.1% | -57.6% | +0.0% | – | |
| – | – | +1,396.3% | -29.9% | +0.8% | -104.8% | -35.9% | +10,264.9% | +1,341.4% | – | -10.1% | -118.9% | – | |
| – | – | +9,711,700.0% | +43.6% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -98.9% | -120.8% | – | +1,232.1% | -19.8% | -46.0% | +1,266.2% | +80.8% | -100.9% | +756.1% | -41.5% | – | |
| – | -128.8% | – | – | – | -20.5% | +377.8% | +262.9% | -218.2% | – | -65.5% | +136.4% | – | |
| – | – | – | – | – | – | – | +51.9% | +1.3% | +205.6% | -55.1% | +108.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.